The data has also shown that serum S100B levels are closely associated with infarct volume and are positively correlated with the risk of malignant infarction or hemorrhagic transformation after thrombolysis as well as with functional outcome in stroke patients (Dassan et al., 2009). This evidence concerns the gene S100B and Stroke.